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In the color-coded key of Figure S1B in the above article, ‘‘S’’ and ‘‘G0/G1’’ were inadvertently switched. A corrected version of
Figure S1 is shown below. Approximately 60%–70% of the cells in each condition are in G0/G1.Annotated (Genic): Transcripts with significant 
overlap to existing annotations. 
Antisense: Transcripts that run antisense to and 
overlap with annotated transcripts. 
Divergent: Transcripts that run antisense to and 
overlap with the 5' promoter of any detected 
transcript. 
ER Enhancer: Transcripts that originate near an 
ER binding site that is far from known 
promoters. 
Other Genic (Poorly Matching Annotated): 
Transcripts that overlap a segment of an 
annotated protein coding gene on either 
strand, but area poor match to the annotation. 
Intergenic: Transcripts that do not fit into the 
categories noted above.
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Figure S1. GRO-Seq Analysis and Transcript Calling in MCF-7 Cells, Related to Figure 1
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